IKKγ NBD Inhibitory Peptide TFA is a potent biomedical product used to inhibit the IKKγ NBD (NEMO binding domain) protein, a key regulator of NF-κB signaling pathway. By specifically targeting this protein, this peptide assists in treating diseases associated with abnormal NF-κB activation, such as inflammation, cancer, and autoimmune disorders.
CAT# | GR2144 |
M.F/Formula | C172H260N49F3O44S1 |
M.W/Mr. | 3807.32 |
Appearance | Solid |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Myristoyl pentapeptide-11 is classified to cosmetic peptide and single peptide, a common saturated fatty acid, w ...
Jingzhaotoxin-III (β-TRTX-Cj1α) is a kind of sodium channel gating modifier which is from the tarantula Chilobra ...
Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...
Trifluoroacetyl tripeptide-2 (TFA-T2) is an innovative peptide compound that has garnered significant attention in dermatolog ...
An overview of Tripeptide-10 Citrulline Signal oligopeptides are commonly synthesized from portions of EMPs and from natural ...